We synthesize mechanisms linking menopausal biology to increased risk of sarcopenic obesity: obesity-driven inflammation, adipokine dysregulation, and lipotoxic flux that impair insulin-AKT signaling and metabolic flexibility, coupled with reduced contractile/endocrine muscle output that worsens adipose phenotype. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.